Journal article
Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.
- Abstract:
-
OBJECTIVE: To determine whether the immunogenicity of a single dose infant priming schedule of serogroup C meningococcal (MenC) conjugate vaccine is non-inferior to a two dose priming schedule when followed by a booster dose at age 12 months. DESIGN: Phase IV open label randomised controlled trial carried out from July 2010 until August 2013 SETTING: Four centres in the United Kingdom and one centre in Malta. PARTICIPANTS: Healthy infants aged 6-12 weeks followed up until age 24 months. INTER...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 414.3KB, Terms of use)
-
- Publisher copy:
- 10.1136/bmj.h1554
Authors
- Publisher:
- BMJ Publishing Group
- Journal:
- BMJ (Clinical research ed.) More from this journal
- Volume:
- 350
- Issue:
- apr01 16
- Pages:
- h1554-h1554
- Publication date:
- 2015-01-01
- DOI:
- EISSN:
-
1756-1833
- ISSN:
-
0959-8138
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:516909
- UUID:
-
uuid:31f566e6-0d0c-4b34-b6cf-f519fb994ecf
- Local pid:
-
pubs:516909
- Source identifiers:
-
516909
- Deposit date:
-
2015-11-28
Terms of use
- Copyright holder:
- BMJ Publishing Group Ltd
- Copyright date:
- 2015
- Notes:
- This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
If you are the owner of this record, you can report an update to it here: Report update to this record